Loading clinical trials...

Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool | Clinical Trials | Clareo Health

WITHDRAWN

Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool

Validation of a Pediatric Abstinence Syndrome Scoring Tool Utilizing a Standardized Hospital-Based Guideline for Iatrogenic Opioid Dependence

NCT00792415•Banner Health

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the validity and reliability of an abstinence syndrome assessment tool used in pediatric patients with iatrogenic opioid dependence.

Detailed Description

None available.

Eligibility

Age

0 - 18 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Pediatric Intensive Care Unit patients ages 2 weeks to 18 years
•Patients receiving continuous opioid infusions for 5 days (at least 120 hours) or more

Exclusion Criteria

•Attending discretion
•Patients with deterioration of medical status requiring interventions of pain control, surgery, sedation, or re-intubation

Locations (1)

Cardon Children's Medical Center

Mesa, Arizona, United States

Key Dates

Start Date

November 1, 2009

Primary Completion Date

April 1, 2010

Completion Date

December 1, 2010

Last Updated

February 11, 2025

Conditions

Substance Withdrawal Syndrome

Opioid Withdrawal Symptoms in Critically Ill Patients

NCT03374722

Substance Withdrawal SyndromeCritical Illness

View study

COMPLETEDPHASE1

Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction

NCT02801357

Substance Withdrawal SyndromeOpiate Addiction+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 11, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool

Inclusion Criteria

Exclusion Criteria

Opioid Withdrawal Symptoms in Critically Ill Patients

Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction

Acute Withdrawal From Smoked Cocaine - 9

The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program

The Effects of One-Time Pregnenolone, Dehydroepiandrosterone (DHEA), or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male Smokers

Therapeutic Massage to Manage Withdrawal Related Anxiety